Ever wondered if we could predict the success of clinical trials before they even start? Saurabh Jain, CEO of Opyl.Ai, reveals how his company uses AI to achieve incredible accuracy rate in predicting trial outcomes. With $25 million raised and three years of development, this innovation is set to revolutionize med tech. Watch the full episode on Innovation and Leadership. #AI #MedTech #ClinicalTrials
Predicting #Clinical Trials with #AI #shorts
Join the Email List
Email has been submitted.
Recent Episodes
- From Microsoft To CEO Of $4B Life360 | Lauren Antonoff, Life360
- Re-engineering a $4 billion company for the age of AI | Linda Tong, CEO at Weblow
- Infiltrating Biker Gangs & Cartels for the CIA | Matthew Hedger
- How Did He Grow to $18B | Seth Streeter, Co-Founder of Mission Wealth
- How Did He Build A $1.5B Licensing Portfolio | Sam Bremner
- Investing in the Future of AI CyberSercurity | Andrew Rubin, Illumio Founder & CEO
- How did He Grow to $6.4B | Tom Shea, Co-Founder & CEO of Onestream
- Fomer Undercover CIA Officer Rescuing Children | Founder and President, ARC
- $5B Crowdfunding Success Story | Ben Miller, Co-Founder & CEO of Fundrise
- See all →